Versant V Luxco S.a r.l.

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Aprea Therapeutics Inc (APRE)

Transaction date 7 Oct 2019

Purchase

Price

420.47

Quantity 69,717 -30.3%

Value US$1,446,185

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2019-10-07	2019-10-07	Aprea Therapeutics Inc (APRE)	B Purchase	69,717 -30.3% 420.47 US$1,446,185	69,717 -30.3%	420.47	US$1,446,185